{"nct_id":"NCT02244502","title":"Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)","status":"UNKNOWN","status_verified_date":"2016-07","start_date":"2014-09","start_date_type":null,"primary_completion_date":"2016-12","primary_completion_date_type":"ESTIMATED","completion_date":"2016-12","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["NVCR"]}